Supply issues and shortages of hormone therapy (HRT).
Updated November 2023: there are currently known supply issues with Testosterone Enantate and Tostran 2% gel. Furthermore, there have been recent supply issues with Sustanon and Estradiol patches. For suitable alternative HRT formulations please see the following link: Alternatives when there are HRT shortages
All endocrine queries from patients and clinicians should now be directed to: firstname.lastname@example.org
- Patient involvement events on intersectionality and gender transition Monday 23 May 2022
- Issues with our phone lines – Tuesday 8 March 2022 Tuesday 8 March 2022
- You can self-refer to the GIC Thursday 18 November 2021
- Show care for the people who care for you Tuesday 2 February 2021